These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 17581329)
1. Upper extremity deep vein thrombosis after suspension of progesterone-only oral treatment. Lapecorella M; Orecchioni A; Dell'Orso L; Mariani G Blood Coagul Fibrinolysis; 2007 Jul; 18(5):513-7. PubMed ID: 17581329 [TBL] [Abstract][Full Text] [Related]
2. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature. Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190 [TBL] [Abstract][Full Text] [Related]
3. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population. Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913 [TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use. Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454 [TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients. Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197 [TBL] [Abstract][Full Text] [Related]
6. Upper-extremity deep vein thrombosis in a patient on clozapine therapy carrying the prothrombin G20210A mutation. Vayá A; Lopez M; Plumé G; Ribes J Pathophysiol Haemost Thromb; 2008; 36(2):105-7. PubMed ID: 19127092 [TBL] [Abstract][Full Text] [Related]
7. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis. Eroglu A; Egin Y; Cam R; Akar N Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947 [TBL] [Abstract][Full Text] [Related]
8. Cyproterone acetate- and ethinyloestradiol-containing oral contraceptive as a risk factor for upper extremity deep venous thrombosis-a case report. Kapur R; Stramrood CA; Schutgens RE; van Asbeck BS Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):160-3. PubMed ID: 19340712 [TBL] [Abstract][Full Text] [Related]
9. Superficial venous thrombosis: prevalence of common genetic risk factors and their role on spreading to deep veins. Milio G; Siragusa S; Minà C; Amato C; Corrado E; Grimaudo S; Novo S Thromb Res; 2008; 123(2):194-9. PubMed ID: 18387654 [TBL] [Abstract][Full Text] [Related]
10. [Mutation frequencies of the thrombophilic state genes in Uzbekistan]. Sadikova ShE; Karimov KhIa; Muminov ShM; Tulakov RP; Boboev KT Tsitol Genet; 2008; 42(6):50-4. PubMed ID: 19253755 [TBL] [Abstract][Full Text] [Related]
12. Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk. Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Doggen CJ Br J Haematol; 2010 Apr; 149(1):118-23. PubMed ID: 20096009 [TBL] [Abstract][Full Text] [Related]
13. Lack of association between hemorheological alterations and upper-extremity deep vein thrombosis. Vaya A; Martinez Triguero M; Romagnoli M; López M; Ricart A; Corella D Clin Hemorheol Microcirc; 2009; 41(4):279-85. PubMed ID: 19318721 [TBL] [Abstract][Full Text] [Related]
14. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis. Saadatnia M; Tajmirriahi M Acta Neurol Scand; 2007 May; 115(5):295-300. PubMed ID: 17489938 [TBL] [Abstract][Full Text] [Related]
15. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305 [TBL] [Abstract][Full Text] [Related]
16. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel? Meurer LN; Slawson JG J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554 [No Abstract] [Full Text] [Related]
18. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Martinelli I; Taioli E; Bucciarelli P; Akhavan S; Mannucci PM Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):700-3. PubMed ID: 10073976 [TBL] [Abstract][Full Text] [Related]
19. Coexistence of left-sided inferior vena cava, deep vein thrombosis of the upper and lower extremities and prothrombotic polymorphisms in a young patient: a case report. Sirlak M; Cakici M; Inan MB; Eryilmaz S; Ustuner E; Atasoy C; Kaya B; Ozyurda U Blood Coagul Fibrinolysis; 2008 Jul; 19(5):443-5. PubMed ID: 18600097 [TBL] [Abstract][Full Text] [Related]